Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02851862 · ClinicalTrials.gov registry record
A Natural History of Late Onset Tay-Sachs Disease
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 10
- Enrollment target
NCT02851862: Completed study, sponsored by Massachusetts General Hospital.
NCT02851862 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02851862 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about the natural history of Late Onset GM2 Gangliosidosis (Tay-Sachs disease and Sandhoff Disease) to inform future clinical trials.
Primary Outcome
Ataxia rating scale incorporating gait, dysarthria, and coordination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-04 |
| Est. Completion | 2025-12 |
What the finished NCT02851862 record still lists
NCT02851862 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02851862 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02851862 about?
NCT02851862 is a clinical study titled "A Natural History of Late Onset Tay-Sachs Disease". The purpose of this study is to learn more about the natural history of Late Onset GM2 Gangliosidosis (Tay-Sachs disease and Sandhoff Disease) to inform future clinical trials.
What is the current status of trial NCT02851862?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2016-04. Estimated completion is 2025-12.
Who is sponsoring clinical trial NCT02851862?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia